SNU-638Homo sapiens (Human)Cancer cell line

Also known as: SNU638

🤖 AI SummaryBased on 8 publications

Quick Overview

SNU-638 is a human gastric cancer cell line derived from ascites, used in cancer research.

Detailed Summary

SNU-638 is a human gastric cancer cell line established from ascites fluid, commonly used in cancer research to study gastric malignancies. It exhibits specific genetic and molecular characteristics that make it a valuable model for investigating cancer biology and therapeutic responses. Research on SNU-638 has focused on understanding genomic alterations, drug resistance mechanisms, and the role of specific genes like ZAK and MET in cancer progression. This cell line is utilized in studies related to chemotherapy resistance, targeted therapies, and molecular profiling to identify potential therapeutic targets and biomarkers.

Research Applications

Genomic and transcriptomic analysisDrug resistance mechanismsTargeted therapy developmentMolecular profilingCancer biology studies

Key Characteristics

Used in gastric cancer researchInvolved in studies of ZAK isoform usagePart of studies on MET and c-MET inhibitorsInvestigated for drug resistance mechanisms
Generated on 6/14/2025

Basic Information

Database IDCVCL_0102
SpeciesHomo sapiens (Human)
Tissue SourceAscites[UBERON:UBERON_0007795]

Donor Information

Age48
Age CategoryAdult
SexMale

Disease Information

DiseaseGastric adenocarcinoma
LineageEsophagus/Stomach
SubtypeStomach Adenocarcinoma
OncoTree CodeSTAD

DepMap Information

Source TypeKCLB
Source IDACH-001664_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg282Trp (c.844C>T)Unspecified-PubMed=21173094, PubMed=1373872
MutationSimpleMETp.Asn375Ser (c.1124A>G)Heterozygous-PubMed=27822414

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
10
D16S539
11,13
D18S51
14,16
D21S11
30.2,31
D3S1358
15
D5S818
10,13,14,15
D7S820
9,10
D8S1179
11,13
FGA
17,26,27
Penta D
9
Penta E
14,18
TH01
7
TPOX
8,11
vWA
14,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.

Kragh M., Horak I.D., Chung H.C., Rha S.Y.

Int. J. Cancer 143:151-159(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.

Firestein R., Zhang Z.-M.

Nat. Commun. 5:3830.1-3830.8(2014).

Biology of SNU cell lines.";

Ku J.-L., Park J.-G.

Cancer Res. Treat. 37:1-19(2005).

Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization.

Okanoue T., Inazawa J.

Cancer Sci. 96:100-110(2005).

Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.

Chung Y.M., Park S.-H., Park J.K., Kim Y.-T., Kang Y.-K., Yoo Y.D.

Cancer Lett. 159:95-101(2000).

Characterization of chromosomal aberrations in human gastric carcinoma cell lines using chromosome painting.

Chun Y.-H., Kil J.-I., Suh Y.-S., Kim S.-H., Kim H., Park S.-H.

Cancer Genet. Cytogenet. 119:18-25(2000).

Establishment and characterization of human gastric carcinoma cell lines.

Bang Y.-J., Kim Y.I., Kim J.-P.

Int. J. Cancer 70:443-449(1997).